Loading clinical trials...
Loading clinical trials...
Establishing the diagnosis of Ehlers Danlos Syndromes (EDS)/generalized hypermobility spectrum disorders (G-HSD) is often problematic for patients. The absence of a precise unifying diagnosis in patie...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Health Network, Toronto
NCT05212129 · Functional Gastrointestinal Disorders, Hypermobile Ehlers-Danlos Syndrome, and more
NCT05994664 · Vascular Ehlers-Danlos Syndrome
NCT05976841 · Ehlers-Danlos Syndrome, Vascular Type
NCT07464093 · Ehlers-Danlos Syndrome (EDS), Hypermobile EDS (hEDS), and more
NCT07151274 · Ehlers-Danlos Syndrome (EDS)
GoodHope EDS - Toronto General Hospital
Toronto, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions